Materiały źródłowe

• #1 Inflammatory Breast Cancer (IBC) | Susan G. Komen®

  https://www.komen.org/breast-cancer/treatment/by-diagnosis/inflammatory-breast-cancer/

  Inflammatory breast cancer (also called IBC) is an aggressive breast cancer. […] The main warning signs of inflammatory breast cancer are swelling and redness in the breast. Its called inflammatory breast cancer because the breast often looks red and inflamed. […] Warning signs of inflammatory breast cancer include: Swelling or enlargement of the breast, Redness of the breast (may also be a pinkish or purplish tone), Dimpling or puckering of the skin of the breast (may look and feel like an orange peel), Pulling in of the nipple, Breast pain. […] Signs of inflammatory breast cancer tend to arise quickly, within weeks or months. With other breast cancers, warning signs may not occur for years. […] Routine mammography may miss inflammatory breast cancer because of its rapid onset, which may happen in between scheduled mammograms.

• #2 What is inflammatory breast cancer (IBC)? | MD Anderson Cancer Center

  https://www.mdanderson.org/cancerwise/9-questions-about-inflammatory-breast-cancer–answered.h00-159306990.html

  Inflammatory breast cancer (IBC) is a rare subtype of breast cancer whose symptoms typically first appear as breast skin changes. It accounts for only about 2% to 4% of new breast cancer diagnoses annually. But because its so aggressive, IBC makes up a disproportionate number of breast cancer-related deaths each year. […] We continue to make inroads in the diagnosis and treatment of this disease. […] Unlike other types of breast cancer, inflammatory breast cancer doesn’t usually show up as a lump or appear on a screening mammogram. That is why it’s so often misdiagnosed. […] But patients usually notice skin changes and breast swelling that develop fairly quickly and prompt a visit to the doctor. […] Inflammatory breast cancer is always considered at least stage III, though, no matter how early you catch it. So, the sooner you can diagnose it and start treatment before it progresses to stage IV, the better chance you have of a cure.

• #3 Inflammatory Breast Cancer – NCI

  https://www.cancer.gov/types/breast/ibc-fact-sheet

  How is inflammatory breast cancer diagnosed? […] Minimum criteria for a diagnosis of inflammatory breast cancer include the following: A rapid onset of erythema (redness), edema (swelling), and a peau d’orange appearance (ridged or pitted skin) and/or abnormal breast warmth, with or without a lump that can be felt. […] Initial biopsy samples from the affected breast show invasive carcinoma. […] Further examination of tissue from the affected breast should include testing to see if the cancer cells have hormone receptors (estrogen and progesterone receptors) or if they have greater than normal amounts of the HER2 gene and/or the HER2 protein (HER2-positive breast cancer). […] Proper diagnosis and staging of inflammatory breast cancer helps doctors develop the best treatment plan and estimate the likely outcome of the disease.

• #4 Inflammatory Breast Cancer – StatPearls – NCBI Bookshelf

  https://www.ncbi.nlm.nih.gov/books/NBK564324/

  Inflammatory breast cancer (IBC) is a rare subtype of locally advanced breast cancer according to the TNM breast cancer staging system. Despite its low incidence, IBC contributes to 7% of breast cancer caused mortality. This activity describes the evaluation and management of inflammatory breast cancer and highlights the role of the interprofessional team in the care of patients with this condition. […] The current American Joint Committee on Cancer (AJCC) guidelines define IBC as a separate clinicopathologic entity with erythema and edema occupying at least one-third of the breast, that can extend to the whole breast and across to the contralateral breast involving the mediastinum, upper extremities, and neck area. […] Diagnostic criteria: IBC is designated as T4d in the American Joint Committee on Cancer (AJCC) Tumor, Node, Metastasis (TNM) staging system. All of the following criteria must be met for a diagnosis of IBC.

• #4 Inflammatory Breast Cancer – StatPearls – NCBI Bookshelf

  https://www.ncbi.nlm.nih.gov/books/NBK564324/

  The diagnosis of inflammatory breast cancer is based upon the characteristic clinical presentation and core needle biopsy showing invasive carcinoma of the breast. A very high index of suspicion should be present when evaluating a patient who presents with rapidly progressive inflammatory skin changes of the breast with no improvement with antibiotics. Patients with suspected inflammatory breast cancer should undergo breast imaging and biopsy. […] Both national comprehensive cancer network and international inflammatory breast cancer expert guidelines recommend intensive therapy for patients with primary inflammatory breast cancer to achieve the best local control and survival outcome via a tri-modality approach: Systemic therapy, surgery, and radiation therapy. An interprofessional team approach is critical in the care of patients with inflammatory breast cancer.

• #5 Inflammatory breast cancer: a clinical diagnosis | SMJ

  http://www.smj.org.sg/article/inflammatory-breast-cancer-clinical-diagnosis

  IBC is clinically diagnosed by a short duration of symptoms, typical clinical signs on examination of the affected breast, and pathological diagnosis of breast carcinoma either through skin biopsy or core/needle biopsy of the underlying lump, if present. […] Rapidly progressing diffuse erythema (pink or mottled pink hue) and oedema of more than one-third of the breast distinguishes IBC from noninflammatory locally advanced breast cancer (LABC) with skin involvement. […] In a consensus statement, an international expert panel agreed that the following minimum criteria are required for the diagnosis of IBC: a history of rapid onset of breast erythema; a duration of history of no more than six months; oedema and/or peau dorange and/or warm breast (with or without an underlying palpable mass); erythema occupying at least one-third of the breast; and pathological confirmation of invasive carcinoma. […] However, the panel also strongly recommended that skin biopsy be done in all patients suspected to have IBC, as it may confirm the presence of dermal tumour emboli and may also give the pathological diagnosis of carcinoma if no underlying lump or regional metastatic lymphadenopathy is detected.

• #6 Inflammatory breast cancer defined: proposed common diagnostic criteria to guide treatment and research

  https://pmc.ncbi.nlm.nih.gov/articles/PMC8926970/

  The hallmark of IBC is the sudden onset of signs and symptoms within a 6-month period prior to the diagnosis of invasive disease. This rapid onset of clinical features distinguishes IBC from non-inflammatory locally advanced breast cancer (LABC) arising from a more indolent subtype of invasive breast cancer, often neglected for years. […] As with erythema, thickening of the skin of the breast is also understood to be a consequence of dermal lymphatic involvement with tumor emboli. […] Asymmetrical enlargement of the affected breast has been used as a criterion for the diagnosis of IBC since 1978. […] The erythema associated with IBC is believed to be due to dilated capillaries associated with tumor emboli within the papillary or reticular dermis of the skin of the breast. […] Changes in the nipple may be a characteristic of IBC, including nipple inversion, nipple flattening, or crusting of the nipple/areolar complex.

• #7 Defining and Demystifying Inflammatory Breast Cancer | Blog | AACR

  https://www.aacr.org/blog/2023/12/15/sabcs-2023-defining-and-demystifying-inflammatory-breast-cancer/

  It took me almost five months to get a diagnosis, and Im just amazed that I did not have metastatic disease by that point, Mason told the attendees of the 2023 San Antonio Breast Cancer Symposium (SABCS), held December 5-9, during an educational session about inflammatory breast cancer (IBC), the disease that changed the trajectory of her life. […] While IBC research has come a long way since 1994, patients still struggle to receive an accurate and timely diagnosis and understand their treatment options. […] Much of the confusion stems from IBCs ambiguous symptoms and presentation, explained Filipa Lynce, MD, senior physician and director of the Inflammatory Breast Center at Dana-Farber Cancer Institute, an assistant professor of medicine at Harvard Medical School, and moderator of the session. Lynce described the diagnostic criteria for IBC, including: A concurrent diagnosis of invasive (stage 3 or 4) breast cancer, Rapid progression within six months, Erythema (skin redness) involving one-third or more of the affected breast, In some cases, swelling, warmth, a palpable mass, dimpled or pitted skin (peau dorange), and involvement of the dermal lymph nodes.

• #8

  https://link.springer.com/article/10.1007/s10549-021-06434-x

  Inflammatory breast cancer is a deadly and aggressive type of breast cancer. A key challenge relates to the need for a more detailed, formal, objective definition of IBC, the lack of which compromises clinical care, hampers the conduct of clinical trials, and hinders the search for IBC-specific biomarkers and treatments because of the heterogeneity of patients considered to have IBC. […] The experts identified through consensus several defining characteristics of IBC, including factors related to timing of onset and specific symptoms. These reflect common pathophysiologic changes, sometimes detectable on biopsy in the form of dermal lymphovascular tumor emboli and often reflected in imaging findings. […] To move beyond subjective clinical diagnosis of IBC, we propose a quantitative scoring system to define IBC, based on clinical, pathologic, and imaging features. This system is intended to predict outcome and biology, guide treatment decisions and inclusion in clinical trials, and increase diagnostic accuracy to aid basic research; future validation studies are necessary to evaluate its performance.

• #8

  https://link.springer.com/article/10.1007/s10549-021-06434-x

  The hallmark of IBC is the sudden onset of signs and symptoms within a 6-month period prior to the diagnosis of invasive disease. […] The diagnosis of IBC is categorized as clinical stage T4d. […] Therefore, we propose and describe a diagnostic scoring system developed by expert consensus that accounts for the variable presentation of IBC. […] We propose a composite definition of IBC based upon a graded scoring system of 13, where 3 is definitively associated with IBC and 1 less specific for IBC compared with non-inflammatory LABC. […] The purpose of applying the proposed IBC Scoring System to clinical practice is to facilitate a diagnosis of IBC in the most prompt, accurate, and consistent manner possible. […] A complete evaluation of any potential clinical presentation of IBC includes a skin punch biopsy and breast imaging, MR imaging being the most definitive modality. […] The presence of dermal lymphatic emboli is not required for the diagnosis using the proposed IBC Scoring System, provided other criteria can be assessed and a score of 42 has been documented.

• #9 Inflammatory breast cancer – Diagnosis and treatment – Mayo Clinic

  https://www.mayoclinic.org/diseases-conditions/inflammatory-breast-cancer/diagnosis-treatment/drc-20355417

  Inflammatory breast cancer is a clinical diagnosis that often starts with a discussion of your health history and an exam of the breast. Other tests include imaging tests and removing some cells for testing. […] Tests and procedures used to diagnose inflammatory breast cancer include: A physical exam. Your healthcare professional examines your breast to look for changes in skin color, swelling and other signs of inflammatory breast cancer. Imaging tests. Imaging tests make pictures of the body. Your healthcare professional may recommend a breast X-ray, called a mammogram, or a breast ultrasound to look for signs of cancer in your breast. Additional imaging tests, such as an MRI, may be recommended in certain situations. Removing a sample of tissue for testing. A biopsy is a procedure to remove a sample of tissue for testing in a lab. The tissue might be removed using a needle that is put through the skin and into the suspected cancer cells. A skin biopsy also may be helpful. This type of biopsy removes a sample of skin cells. The sample is tested in a lab to see if it is cancer.

• #9 Inflammatory breast cancer – Diagnosis and treatment – Mayo Clinic

  https://www.mayoclinic.org/diseases-conditions/inflammatory-breast-cancer/diagnosis-treatment/drc-20355417

  If you’re diagnosed with inflammatory breast cancer, you may have other tests to see if the cancer has spread. These tests help your healthcare team find out the extent of your cancer, also called the stage. Cancer staging tests often involve imaging tests. The tests might look for signs of cancer in your lymph nodes or in other parts of your body. Your healthcare team uses the cancer staging test results to help create your treatment plan. […] Imaging tests may include MRI, CT, bone scans and a positron emission tomography scan, which also is called a PET scan. Not every test is right for every person. Talk with your healthcare professional about which tests are best for you.

• #10 Inflammatory Breast Cancer (IBC)| Baptist Health

  https://www.baptisthealth.com/care-services/conditions-treatments/inflammatory-breast-cancer

  Inflammatory breast cancer (IBC) is a rare and extremely aggressive and rapidly growing type of breast cancer. It often progresses in a matter of weeks or months. Usually, at diagnosis, IBC is already in stage III or IV because the breast cancer cells have grown into the skin and possibly spread to other tissue. […] Often, IBC can be difficult to diagnose because the symptoms are like a breast infection and there is not the characteristic lump or mass like in other types of breast cancer, which makes it harder to detect during a breast exam or with a mammogram. […] The most common symptoms of IBC are when the breast is red, swollen, and tender. This occurs when cancer cells block the lymphatic vessels in the skin that cover the breast. […] IBC can be difficult to diagnose because of the similar symptoms it shares with a breast infection, which is less serious. The most common symptoms and first signs of IBC are related to the inflammation of the breast. The breast will appear red and swollen (sometimes purple in color like a bruise) and is painful and tender. The symptoms of inflammatory breast cancer progress rapidly, over the course of 3-6 weeks.

• #11 Inflammatory Breast Cancer > Fact Sheets > Yale Medicine

  https://www.yalemedicine.org/conditions/inflammatory-breast-cancer

  Redness and inflammation are common signs of an infection or injury, but when these symptoms occur in the breast, they may signal a rare type of breast cancer known as inflammatory breast cancer (IBC). […] IBC is among the most aggressive types of breast cancer, and it can progress over the course of months or even just a few weeks. Because of this, early diagnosis and care are crucial. […] How is inflammatory breast cancer diagnosed? […] The doctor will ask questions about symptoms, including when they began and how quickly they progressed. He or she will need to conduct a physical exam to check for findings associated with IBC. […] Other tests are necessary to confirm the diagnosis of IBC, and to rule out other possible causes of symptoms, including: […] Imaging tests can help doctors see tumors, thickened skin, or other abnormalities in breast tissue. Tests may include a mammogram, breast ultrasound, and/or a magnetic resonance imaging (MRI) study of the breast.

• #11 Inflammatory Breast Cancer > Fact Sheets > Yale Medicine

  https://www.yalemedicine.org/conditions/inflammatory-breast-cancer

  Biopsy of breast tissue is required for diagnosis. In this procedure, a health care provider removes a small piece of breast tissue, usually with a needle. A pathologist analyzes the tissue sample in a lab to check for the presence of cancer cells and other indications of IBC. […] If the doctor diagnoses IBC, he or she will order some additional tests to see whether the cancer has spread to other parts of the body. This process is known as staging. […] Its worth noting that many of the symptoms of IBC are similar to those of other, more common conditions such as an infection of the breast tissue. Because of this, IBC is sometimes initially misdiagnosed and treated with antibiotics, which do not improve symptoms or deal with the underlying cancer. […] How is inflammatory breast cancer treated?

• #12 Inflammatory Breast Cancer Diagnosis | MD Anderson Cancer Center

  https://www.mdanderson.org/cancer-types/inflammatory-breast-cancer/inflammatory-breast-cancer-diagnosis.html

  Getting the right diagnosis is the first step in cancer treatment. MD Anderson has experts who specialize in the diagnosis of breast cancer and its subtypes, including inflammatory breast cancer. Since inflammatory breast cancer is a fast-growing disease, an early, accurate diagnosis greatly increases the chances for successful treatment. […] Since symptoms of inflammatory breast cancer often are similar to those of mastitis, a type of breast infection, doctors first may prescribe antibiotics. If the symptoms do not improve or grow worse, patients should have diagnostic tests performed as soon as possible. These may include: […] The first diagnostic procedure for breast cancer is typically an imaging exam. Breast imaging is usually carried out with a mammogram, breast ultrasound and breast MRI.

• #13 Inflammatory Breast Cancer | Froedtert & MCW

  https://www.froedtert.com/breast-cancer/inflammatory

  Inflammatory breast cancer differs from other breast cancer types in that it usually does not have a distinct lump or solid mass. […] This makes inflammatory breast cancer difficult to diagnose. A prompt, accurate diagnosis of your symptoms and an appropriate treatment plan are the key to improving your chances of survival. […] Because inflammatory breast cancer is so rare and symptoms are similar to a breast infection, it can be a challenge to diagnose. Redness in the skin of the breast may lead a physician to suspect a breast infection such as mastitis and prescribe antibiotics, which can delay treatment for inflammatory breast cancer. […] If your doctor prescribes antibiotics, and your symptoms do not improve within three days of taking the medication, you need to contact your doctor. Your doctor should suspect that there is cancer in the breast and immediately refer you to a team of physicians who specialize in treating inflammatory breast cancer.

• #14 Inflammatory Breast Cancer: Symptoms, Treatment, Research | Breast Cancer Research Foundation

  https://www.bcrf.org/about-breast-cancer/inflammatory-breast-cancer/

  Inflammatory breast cancer (IBC) is a rare but very aggressive subtype of the disease, accounting for one to five percent of all breast cancers diagnosed in the U.S. […] The signs and symptoms of IBC differ from other breast cancers, and researchers are focused on gaining a better understanding of the disease particularly because of its fast-growing nature and prevalence in younger and Black women. […] Inflammatory breast cancer is different from other breast cancers in several key ways. It often doesn’t cause a lump or other more-common symptoms or show up on a mammogram, so it can be difficult to diagnose. […] Unlike other breast cancers, inflammatory breast cancer doesn’t form distinct lumps, which makes it difficult to diagnose through standard breast cancer imaging tests. Instead, IBC is diagnosed by a biopsy of a small sample of the affected area.

• #15 Inflammatory carcinoma of the breast | Radiology Reference Article | Radiopaedia.org

  https://radiopaedia.org/articles/inflammatory-carcinoma-of-the-breast?lang=us

  Mammographic findings include tumor mass and malignant microcalcifications. More specifically, inflammatory changes such as extensive skin and trabecular thickening/coarsening, and/or diffusely increased breast density are important clues that should lead the radiologist to suggest the diagnosis. […] In cases where an image-guided biopsy of the underlying intraparenchymal mass or axillary lymph nodes does not give the diagnosis, a skin biopsy may be indicated. Inflammatory breast cancer has a tendency to metastasize at an early stage. […] Unlike other types of breast cancer in which surgery is the first modality of treatment, chemotherapy before surgery or radiation therapy is the current standard treatment.

• #16 Inflammatory Breast Cancer Has Diagnostic Challenges, Requires More Awareness

  https://www.onclive.com/view/expert-discusses-the-diagnosis-and-treatment-of-inflammatory-breast-cancer

  Inflammatory breast cancer (IBC) is commonly misdiagnosed because it is a rare form of breast cancer that many oncologists do not see frequently. […] If a physician suspects IBC, it can be detected with a few different imaging tools, such as ultrasounds or MRI mammograms. The problem with these tests is that they are not completely reliable in detecting IBC; a mammogram alone, for example, only has about a 68% detection rate of IBC. However, in combination with ultrasound, the detection rate is around 98% to 100%. […] The idea is to make sure everybody has awareness of IBC, which is to recognize the swelling of the breast, redness, and peau d’orange, which is commonly misdiagnosed as an infection. […] However, mammograms do not always detect the disease very well. That would require using ultrasound or MRI mammography to provide more details.

• #17 Inflammatory Breast Cancer Has Diagnostic Challenges, Requires More Awareness

  https://www.onclive.com/view/expert-discusses-the-diagnosis-and-treatment-of-inflammatory-breast-cancer

  For diagnosis, a mammogram is probably 1 of the most commonly used in the breast cancer community, but the detection rate of IBC is about 68%. When you use ultrasound or MRI mammography, you could actually bring it up to the 98% to 100% ranges. […] The current strategy is to receive neoadjuvant chemotherapy, regardless of the molecular subtypes. […] The best outcome is always achieving a pCR with the use of systemic treatment, and that is our goal.

• #18 Imaging Modalities in Inflammatory Breast Cancer (IBC) Diagnosis: A Computer-Aided Diagnosis System Using Bilateral Mammography Images

  https://www.mdpi.com/1424-8220/23/1/64

  Mammography is one of the primary imaging modalities used in IBC diagnosis worldwide. Mammography shows palpable tumor mass, a large calcification area, and/or parenchymal distortion, and skin thickening over the breast with or without a breast mass. […] The system’s performance is evaluated according to the accuracy, recall, precision, F1 score, and area under the curve. The system achieved accuracy in the range of 92.3–100%. […] This paper proposes a model to extract IBC markers and a rule-based fuzzy logic diagnosis model using mammography images. […] The study showed that a primary breast lesion was detected in 98%, 68%, and 94% of the patients by MRI, mammography, and ultrasound, respectively. […] Most studies reported that MRI is the most accurate imaging modality in diagnosing IBC. However, MRI may not be easily accessible to women in low and middle-income countries (LMIC) and underserved areas. […] The proposed fuzzy-based CADx has been designed based on transfer learning from human expertise to the fuzzy classifier, which does not require a training stage and does not require a large dataset.

• #19 Inflammatory breast cancer: Clinical features and treatment – UpToDate

  https://www.uptodate.com/contents/inflammatory-breast-cancer-clinical-features-and-treatment

  Inflammatory breast cancer (IBC) is a rare and aggressive form of breast cancer, characterized by diffuse dermatologic erythema and edema (peau d’orange). […] The diagnosis of inflammatory breast cancer (IBC) is based upon the characteristic clinical presentation and the presence of invasive carcinoma on breast core needle biopsy. […] IBC may be suspected in a patient who presents with rapidly progressive inflammation of the breast with no improvement with antibiotics. The initial evaluation focuses on establishing a diagnosis of invasive breast cancer, with subsequent evaluations to confirm histology and assess the extent of involvement. All patients with suspected IBC undergo breast imaging and biopsy. […] Suspected IBC should be imaged with diagnostic mammogram on the affected side and screening mammogram on the contralateral side, with accompanying ultrasound of the breast and regional lymph nodes.

• #20 Inflammatory Breast Cancer Symptoms, Diagnosis, and Treatment – Iowa Radiology

  https://www.iowaradiology.com/inflammatory-breast-cancer-symptoms-diagnosis-and-treatment/

  Inflammatory breast cancer (IBC) is a rare and particularly aggressive form of breast cancer, in which cancer cells clog the lymph vessels. […] IBC is most often diagnosed after the patient or her doctor sees or feels changes in the breast as described above. At this point, the doctor will likely order a mammogram, which may show thickened skin and/or a difference in size or density between the two breasts. Often, a breast ultrasound is ordered as well. An ultrasound test can detect enlargement of nearby lymph nodes as well as guide a biopsy, which is necessary for a definitive diagnosis.

• #21 Inflammatory breast cancer: Clinical features and treatment – UpToDate

  https://www.uptodate.com/contents/inflammatory-breast-cancer-clinical-features-and-treatment

  A core needle biopsy of the area of concern in the breast should be obtained to make the initial diagnosis of invasive carcinoma. […] IBC is designated as T4d in the American Joint Committee on Cancer (AJCC) Tumor, Node, Metastasis (TNM) staging system. All of the following criteria must be met for diagnosis of IBC: Rapid onset of breast erythema, edema and/or peau d’orange, and/or warm breast, with or without an underlying palpable mass; Duration of history no more than six months; Erythema occupying at least one-third of the breast; Pathologic confirmation of invasive carcinoma. […] Routine laboratory tests, including a complete blood count with platelets, liver function tests, and serum alkaline phosphatase, should be obtained in individuals with suspected or diagnosed IBC. […] For diagnosed cases of IBC, we obtain computed tomography (CT) scans of the chest, abdomen, and pelvis (optimally with intravenous contrast), and a bone scan given that many patients have metastatic disease at presentation.

• #22 Case: Inflammatory Breast Cancer – Radiology | UCLA Health

  https://www.uclahealth.org/departments/radiology/education/breast-imaging-teaching-resources/cases/case-inflammatory-breast-cancer

  Typical mammographic findings include global or focal asymmetry, skin thickening, trabecular thickening, diffuse increase in breast density, and stromal coarsening. […] The most common features are asymmetric skin thickening and subcutaneous edema. […] The most common imaging features of IBC are diffuse skin thickening and edema. […] Given the aggressive nature of the disease, PET/CT is useful in initial evaluation and in staging to determine the extent of lymph node involvement and to detect distant metastasis. […] Skin punch biopsy may yield diagnostic results in up to approximately 75% of patients, where tumor emboli in dermal lymphatics may be seen in pathology specimens. […] Both the tissue diagnosis and clinical presentation are required for diagnosis.

• #22 Case: Inflammatory Breast Cancer – Radiology | UCLA Health

  https://www.uclahealth.org/departments/radiology/education/breast-imaging-teaching-resources/cases/case-inflammatory-breast-cancer

  Patients present with rapid onset (typically less than 3 months) of asymmetric breast enlargement accompanied by tissue thickening, erythema, induration, and warmth involving greater than one third of the breast tissue. […] The pathognomonic finding is dimpling of the skin known as peau d’orange, which occurs due to obstruction of the dermal lymphatics by the tumor emboli. […] In general, the clinical symptoms mimic mastitis; however, inflammatory breast cancers will not respond to 1-2 week trials of antibiotics treatment. […] A palpable breast mass is present in approximately 50% of the cases. […] Inflammatory breast cancer accounts for approximately 1-3% of all breast cancers. […] Invasion of the dermal lymphatics by tumor cells is pathognomonic for inflammatory breast cancer but is not necessary to clinch the diagnosis.

• #23 Inflammatory Breast Cancer: Symptoms, Risk Factors, Diagnosis, Treatment

  https://www.businessinsider.com/guides/health/conditions-symptoms/inflammatory-breast-cancer

  After giving your doctor a detailed history of the symptoms you’re experiencing, they’ll examine your breasts and lymph nodes. If they suspect IBC, they’ll likely perform a breast imaging test. […] One of the most common imaging tests used to diagnose IBC is a mammogram, which provides X-ray images that may show suspicious masses and other breast changes. […] Your doctor may choose to pair the mammogram with an ultrasound for clearer results. […] If the imaging tests indicate something unusual, your doctor will likely order a breast biopsy to confirm a diagnosis. […] Once an IBC diagnosis is made, your doctor will order staging tests. […] If the IBC is stage IV it means the cancer has spread to other organs such as the bones, lungs, or liver. […] A newer, more expensive test that’s becoming increasingly popular is the PET/CT scan, which can examine cancer on a cellular level.

• #23 Inflammatory Breast Cancer: Symptoms, Risk Factors, Diagnosis, Treatment

  https://www.businessinsider.com/guides/health/conditions-symptoms/inflammatory-breast-cancer

  Treatment for IBC takes about six months to a year, according to Golshan. […] Typically, IBC is treated first with chemotherapy, which involves taking drugs aimed at shrinking the tumor. […] As long as the cancer has responded positively to chemo, surgery is the next step. […] After surgery, the final step may be radiation therapy, which uses high-powered beams of energy aimed at the chest and armpit area to destroy any remaining cancer cells. […] The five-year survival rate for IBC is around 40% but it’s important to note there are multiple factors that can affect someone’s outlook, including their overall health, how early they were diagnosed and treatment was first administered, and how much the cancer has spread. […] For example, a 2014 study found that five- and 10-year survival rates were higher among patients who received a combination of chemotherapy, surgery, and radiation compared to those who only had one or two of these treatment types. […] Research has also shown there’s been a significant improvement in survival rates for IBC patients over the last two decades.

• #24 Inflammatory Breast Cancer Diagnosis | MD Anderson Cancer Center

  https://www.mdanderson.org/cancer-types/inflammatory-breast-cancer/inflammatory-breast-cancer-diagnosis.html

  In inflammatory breast cancer, imaging exams may not reveal a distinct breast lump. Instead, they may show skin thickening or enlarged lymph nodes. In these cases, doctors will need to retrieve some suspected cancer tissue. The process of retrieving and examining this tissue under a microscope is called a biopsy. […] For inflammatory breast cancer, patients usually undergo an image-guided core needle biopsy. During this procedure, a live image of the breast tissue helps doctors guide a needle to suspected cancer tissue. In many cases, this biopsy is performed during the initial imaging exam in order to speed up the diagnosis. […] If the biopsy reveals cancerous tissue, additional images and biopsies may be needed to determine the exact scope of the disease. This part of the diagnosis shows whether the cancer has spread to nearby lymph nodes or other parts of the body.

• #25 Inflammatory Breast Cancer – Diagnosis & Disease Information

  https://www.cancertherapyadvisor.com/ddi/inflammatory-breast-cancer/

  The article emphasizes the importance of early diagnosis and outlines the diagnostic process involving physical examination, mammography, ultrasonography, biopsy, and staging. […] Due to the aggressive nature of IBC, expedite diagnostic workup, including biopsy and imaging, for any suspicious cases. Early diagnosis and prompt treatment initiation are critical for improving patient outcomes. […] Typically, IBC is diagnosed by biopsy and/or imaging. Mammography, ultrasonography, or magnetic resonance imaging can confirm the presence of swollen or abnormal tissue. However, an obvious breast lump or mass may not always be present in patients with IBC. […] The biopsy will indicate the presence or lack of either estrogen receptor, progesterone receptor, or ERBB2 (formerly known as HER2), as these inform breast cancer treatment options. Biopsy and histopathology can also confirm the diagnosis of IBC. For example, scattered tumor emboli on a skin biopsy are a key histopathologic finding of IBC.

• #26 Inflammatory breast cancer defined: proposed common diagnostic criteria to guide treatment and research

  https://pmc.ncbi.nlm.nih.gov/articles/PMC8926970/

  Dermal lymphovascular tumor cell emboli are regarded as the classic histological feature of IBC. […] We propose a composite definition of IBC based upon a graded scoring system of 13, where 3 is definitively associated with IBC and 1 less specific for IBC compared with non-inflammatory LABC. […] The purpose of applying the proposed IBC Scoring System to clinical practice is to facilitate a diagnosis of IBC in the most prompt, accurate, and consistent manner possible. […] A complete evaluation of any potential clinical presentation of IBC includes a skin punch biopsy and breast imaging, MR imaging being the most definitive modality. […] We acknowledge that our proposed IBC Scoring System requires validation to evaluate its performance, refinement of the criteria, their weight in the total score, or the thresholds for diagnosis may require refinement.

• #27 What You Should Know About Inflammatory Breast Cancer

  https://mnoncology.com/resources/blog/what-you-should-know-about-inflammatory-breast-cancer

  Inflammatory breast cancer usually does not have hormone receptors. Other types of breast cancer may be fueled by estrogen or progesterone. […] Inflammatory breast cancer can be hard to diagnose because it can seem like other conditions such as a milk duct infection which either goes away on its own or with antibiotics. […] If an oncologist suspects inflammatory breast cancer, he or she will most likely order a biopsy and some form of imaging test. […] If cancer is detected, CT scans, lymph node biopsies, and bone scans are used to stage cancer and determine if it has spread to other parts of the body. […] Oncologists usually treat inflammatory breast cancer first with chemotherapy, then with surgery, followed by radiation therapy treatment.

• #28 Inflammatory Breast Cancer Diagnosis | MD Anderson Cancer Center

  https://www.mdanderson.org/cancer-types/inflammatory-breast-cancer/inflammatory-breast-cancer-diagnosis.html

  If the patient is diagnosed with inflammatory breast cancer, doctors will also analyze the cancer cells to determine the diseases molecular receptor subtype. By understanding the subtype, they can develop a comprehensive, personalized treatment plan. […] A cancers stage is used to describe the extent of the cancer in the patients body. Doctors use the stage to plan treatment and make a prognosis. […] Inflammatory breast cancer uses the same staging system as non-inflammatory breast cancer. The disease is considered at least a stage III cancer. If it has spread beyond the breast and nearby lymph nodes, it is stage IV.

• #29 Inflammatory Breast Cancer: Symptoms, Treatment, Research | Breast Cancer Research Foundation

  https://www.bcrf.org/about-breast-cancer/inflammatory-breast-cancer/

  Because it’s difficult to detect early by mammograms and other imaging techniques, inflammatory breast cancer is often diagnosed at a locally advanced stage (usually at least stage 3) because breast cancer cells have grown into the skin. […] For about one-third of patients at diagnosis, their IBC is already stage 4/metastatic, having spread to distant parts of the body. […] Since inflammatory breast cancer has, by definition, reached lymph vessels and has caused changes in the skin, it’s likely already spreading, making it a challenge to treat. […] For stage 3 cases where the inflammatory breast cancer has not spread outside the breast or nearby lymph nodes, chemotherapy is often used first to shrink the tumor. […] Most women receive two different chemotherapies—anthracyclines (such as doxorubicin/Adriamycin) and taxanes (such as paclitaxel/Taxol or docetaxel/Taxotere)—either together or sequentially. […] Because inflammatory breast cancer is often diagnosed at a later stage, it tends to have a worse prognosis than other types of breast cancer.

• #30 Inflammatory Breast Cancer (IBC) | Susan G. Komen®

  https://www.komen.org/breast-cancer/treatment/by-diagnosis/inflammatory-breast-cancer/

  Inflammatory breast cancer may first be mistaken for an infection or mastitis because of the redness and swelling, and the frequent lack of a breast lump. […] Inflammatory breast cancer may be diagnosed based on clinical appearance, but a biopsy is needed to confirm the diagnosis of invasive breast cancer. […] A biopsy also gives important information on the tumor, such as hormone receptor status and HER2 status. These factors help guide treatment. […] About one-third of women with inflammatory breast cancer have metastases (metastatic breast cancer) when they are diagnosed. […] For this reason, when inflammatory breast cancer is diagnosed, tests for metastases are done to see if its spread to other parts of the body. […] Inflammatory breast cancer is treated with a combination of: Chemotherapy, Surgery, Radiation therapy.

• #30 Inflammatory Breast Cancer (IBC) | Susan G. Komen®

  https://www.komen.org/breast-cancer/treatment/by-diagnosis/inflammatory-breast-cancer/

  The first treatment for inflammatory breast cancer is neoadjuvant chemotherapy, usually with an anthracycline-based chemotherapy and a taxane-based chemotherapy. […] Surgery for inflammatory breast cancer is almost always a mastectomy with an axillary lymph node dissection. […] Treatments after surgery and radiation therapy depend on treatments given before surgery and tumor characteristics, such as hormone receptor status and HER2 status. […] Research is ongoing to improve treatment for inflammatory breast cancer. […] New therapies are being studied in clinical trials. The results of these trials will decide whether these therapies will become part of the standard of care.

• #31 Why diagnosing inflammatory breast cancer is hard and how to overcome the challenges: a narrative review – Le-Petross – Chinese Clinical Oncology

  https://cco.amegroups.org/article/view/86363/html

  The purpose of this narrative review is to summarize the contributors to misdiagnosis or delayed diagnosis of inflammatory breast cancer (IBC) and strategies for expedient diagnosis. […] Patients with IBC often report the disease as initially being misdiagnosed, most commonly as mastitis. […] Several factors contribute to the delayed diagnosis of IBC. One important factor is that IBC is uncommon, and many generalists may not be aware of it in the differential diagnosis of breast skin symptoms. […] Several features of IBC contribute to the low sensitivity of mammography for its detection, and so the diagnosis is based on clinical factors and is thereby subjective. […] The presentation can be highly varied; classic textbook images that do not capture the range of presenting signs and symptoms across skin tones may contribute to missed diagnoses in patients with atypical presentations.

• #31 Why diagnosing inflammatory breast cancer is hard and how to overcome the challenges: a narrative review – Le-Petross – Chinese Clinical Oncology

  https://cco.amegroups.org/article/view/86363/html

  We assert that frank, non-erythematous global skin signs in an enlarged breast with diffuse breast malignancy are sufficient to diagnose IBC if the timing of these signs and findings on biopsy are consistent. […] We further provide images of atypical IBC identified by global breast skin signs, including peau dorange, consistent with IBC in the absence of frank erythema. […] The risk of misdiagnosis is further increased by the low sensitivity of mammography, the most commonly ordered screening exam for breast lesions suspected of being malignant. […] This means physicians who suspect cancer may be wrongly reassured by false-negative findings on a mammogram and miss the diagnosis of IBC instead of moving on to ultrasonography, magnetic resonance imaging (MRI), and biopsy when needed. […] The crucial diagnosis to rule out is IBC, as IBC is always stage III at diagnosis and progresses rapidly to stage IV (incurable) breast cancer when the diagnosis is delayed.

• #31 Why diagnosing inflammatory breast cancer is hard and how to overcome the challenges: a narrative review – Le-Petross – Chinese Clinical Oncology

  https://cco.amegroups.org/article/view/86363/html

  The incidence of IBC is low among women with breast cancer, typically estimated at 23%. […] Therefore, many generalists may never encounter IBC in their careers. […] Our recommendation, based on the literature reviewed, is that any patient with presumed benign mastitis that does not rapidly resolve with recommended therapy for benign disease should undergo breast imaging with mammography and ultrasonography, followed by MRI if available, and biopsy. […] Notably, several groups have reported cases in which experienced breast oncology specialists diagnosed IBC that failed to meet AJCC or international consensus definitions because of the absence of erythema or the lack of concurrent breast edema and peau dorange. […] We assert that some IBC patients will not have frank erythema; however, compelling non-erythematous skin changes such as peau dorange or other skin discolorations due to diffuse disease should be diagnosed as IBC, and patients should be treated with trimodality therapy including neoadjuvant systemic agents, and referral to a dedicated center for enrollment in an IBC-specific trial should be strongly encouraged.

• #32 Inflammatory Breast Cancer Is Often Missed, But May Now Be Easier To Diagnose

  https://www.oncnursingnews.com/view/inflammatory-breast-cancer-is-often-missed-but-may-now-be-easier-to-diagnose

  The goal of this new diagnostic tool is to help not only raise awareness about IBC, but make it easier for providers, including primary care providers, to recognize the signs and make the correct diagnosis. […] According to Tamargo, if providers are not thinking IBC when they see a red swollen breast, it can easily be missed. […] What can be tricky about it is that sometimes there is no mass, and the symptoms can be very progressive [so] it can look like an infection to primary care providers or providers in the community, she said, noting that often, patients meet with her after having been on antibiotics for a while to treat their redness or swelling. […] Tamargo explained that the symptoms are fast-acting and will progress within a 6-month span. Moreover, because there is not always a mass, event though patients may notice changes, their providers might not think of cancer.

• #32 Inflammatory Breast Cancer Is Often Missed, But May Now Be Easier To Diagnose

  https://www.oncnursingnews.com/view/inflammatory-breast-cancer-is-often-missed-but-may-now-be-easier-to-diagnose

  Ryan Tamargo, NP, AONCP, highlights how a new diagnostic tool can help improve accurate inflammatory breast cancer diagnoses. […] The launch of a new, easy-to-use online tool, developed through Susan G Komen, the Milburn Foundation and the Inflammatory Breast Cancer Research Foundation, seeks to improve the rate of accurate inflammatory breast cancer (IBC) diagnoses. […] Unfortunately, IBC is often mistaken for a breast infection because it can present without a breast lump, and it can be hard to see on a mammogramapproximately 30% of patients with IBC receive their first diagnosis when their disease is stage IV. However, the new Inflammatory Breast Cancer (IBC) Scoring System online tool, which is available for free on Komens website, offers a quantitative scoring system to standardize the clinical, pathologic, and imaging features associated with IBC.

• #33 Diagnosis – Inflammatory Breast Cancer Research Foundation

  https://ibcresearch.org/diagnosis/

  Any cellulitis (swelling/redness) of the breast that occurs in a non-gravid (not pregnant), non-lactating (not breast feeding) woman should be assumed to be IBC until biopsy proves otherwise. […] It’s important to advocate for yourself! You may need to push for biopsies. […] Because IBC progresses quickly, waiting to see what happens is not a good idea.

• #34 Inflammatory Breast Cancer Symptoms and Treatment

  https://www.verywellhealth.com/ibc-inflammatory-breast-cancer-430621

  If a mass is noted, a breast biopsy may be performed. If a mass is not present, a skin biopsy will be done on the abnormal area of the affected breast. […] IBC does not always present with a lump like other cancers. Instead, it grows in sheets (sometimes called „nests”) and can spread through the body primarily via the lymphatic system. […] IBC is classified either as stage 3 or stage 4, depending on how far it has spread in the body. […] Treatment for this type of breast cancer can include chemotherapy, hormonal therapy, or targeted therapy. You may also need surgery and radiation to treat IBC.

• #35 Landmark tool developed for diagnosing inflammatory breast cancer – ecancer

  https://ecancer.org/en/news/21594-landmark-tool-developed-for-diagnosing-inflammatory-breast-cancer

  Landmark tool developed for diagnosing inflammatory breast cancer. A first-of-its-kind tool may be able to help doctors better diagnose inflammatory breast cancer (IBC). The novel tool and the findings of the analysis have been recently published in Breast Cancer Research and Treatment. IBC has historically been difficult to diagnose and no changes to diagnostic approach have been made since the 1960s. It is a rare and aggressive type of breast cancer that develops rapidly and can easily be confused with a breast infection and often goes underdiagnosed or misdiagnosed, said Dr. Reshma Jagsi, lead author, Komen Scholar and radiation oncologist. Before the development of this tool, IBC lacked a formal, objective medical definition and diagnosis was often delayed, misdiagnosed or missed. IBC usually presents as swelling or redness of the breast, and not a lump, so it can be missed on a mammogram. The group identified defining characteristics, including clinical, pathologic and imaging features, of IBC that led them to develop a quantitative scoring system for diagnosis. The system, or tool, is intended to increase diagnostic accuracy, predict outcomes, guide treatment decisions and inclusion criteria for clinical trials. This tool will also enable researchers to study the biology of IBC and make discoveries to advance progress towards personalised care for all breast cancer patients. With aggressive breast cancers like IBC, patients need more treatment options, and they need them now. This collaboration is helping us get closer to finding more effective treatments for a type of breast cancer that is difficult to diagnose and treat, said Victoria Wolodzko, Senior Vice President of Mission at Susan G. Komen.

• #36 Inflammatory Breast Cancer (IBC) Scoring System – Susan G. Komen®

  https://www.komen.org/ibc-calculator/

  The IBC Scoring System has not yet completed scientific validation. Results generated from this tool should not be used as a substitute for medical evaluation, diagnosis, or treatment. […] Medical evaluation is required to confirm a negative or positive diagnosis of IBC. […] A diagnosis of IBC ultimately depends on biopsy confirmation of breast cancer and cannot be made based on the IBC Scoring System results, which is intended to be a tool for health care providers to help differentiate IBC from other forms of breast cancer. […] The Inflammatory Breast Cancer (IBC) Scoring System is a proposed set of common diagnostic criteria designed for health care providers to identify IBC. It is being developed to increase diagnostic accuracy, guide treatment decisions and inclusion in clinical trials, and aid basic research. The IBC Scoring System is currently undergoing scientific validation. […] If you are a patient, work with your health care provider to use this tool and interpret the results.

• #37 Inflammatory breast cancer: Clinical features and treatment – UpToDate

  https://www.uptodate.com/contents/inflammatory-breast-cancer-clinical-features-and-treatment

  The role of imaging studies in monitoring response to therapy is discussed separately. […] The approach to treatment of inflammatory breast cancer (IBC) is an aggressive form of locally advanced breast cancer (LABC). […] Neoadjuvant chemotherapy is the standard approach for IBC. We utilize anthracycline- and taxane-based neoadjuvant chemotherapy. […] The rationale for neoadjuvant chemotherapy is to reduce tumor burden, thereby facilitating surgery. […] Mastectomy with axillary dissection is an integral part of the multimodality treatment of IBC. […] RT should be administered to all patients with IBC. […] For patients who respond to neoadjuvant chemotherapy, RT is generally given postoperatively rather than preoperatively because higher doses are more readily achieved. […] The adoption of neoadjuvant chemotherapy has improved outcomes for IBC. Historically, single-modality therapy for IBC was associated with five-year overall survival rates of less than 10 percent. However, with neoadjuvant chemotherapy followed by surgery and radiation therapy, reported overall five-year survival rates range between 30 and 70 percent.

• #38 Inflammatory Breast Cancer – StatPearls – NCBI Bookshelf

  https://www.ncbi.nlm.nih.gov/books/NBK564324/

  The treatment of nonmetastatic inflammatory breast cancer is similar to nonmetastatic noninflammatory locally advanced breast cancer (LABC). The major difference is that sentinel lymph node biopsy and breast conservative therapy are not preferred in IBC even with a very good response to neoadjuvant therapy. […] The standard therapy includes neoadjuvant chemotherapy, followed by locoregional treatment (grade 1B). All patients who have achieved a partial response to neoadjuvant chemotherapy should undergo modified radical mastectomy with axillary dissection and post-mastectomy radiation. […] The diagnosis of inflammatory breast cancer is based upon the characteristic clinical presentation and core needle biopsy showing invasive carcinoma of the breast. A very high index of suspicion should be present when evaluating a patient who presents with rapidly progressive inflammatory skin changes of the breast with no improvement with antibiotics. Patients with suspected inflammatory breast cancer should undergo breast imaging and biopsy.

• #39 Defining and Demystifying Inflammatory Breast Cancer | Blog | AACR

  https://www.aacr.org/blog/2023/12/15/sabcs-2023-defining-and-demystifying-inflammatory-breast-cancer/

  However, a 2014 study showed that only 40% of patients successfully completed trimodal therapy, and a poster presented at SABCS suggested the number may be as low as 25%. […] Lucci argued that the evidence in favor of breast-conserving surgery, in which only a portion of the affected breast is removed, is not sufficient to convince him that the practice is safe for patients with IBC. […] Instead of de-escalating surgery, Lucci suggested prioritizing clear disease margins in the surgical plan and involving plastic surgeons early to optimize breast reconstruction efforts. […] Lucci suggested that radical mastectomy may also benefit patients with metastatic IBCa stark contrast from metastatic non-IBC cases, in which surgery is rarely recommended. […] Jennifer R. Bellon, MD, director of breast radiation oncology at Dana-Farber Cancer Institute and an associate professor of radiation oncology at Harvard Medical School, agreed with the potential for localized therapy to benefit patients with metastatic IBC.

• #40 How To Diagnose Inflammatory Breast Cancer

  https://aqmdi.com/how-to-diagnose-inflammatory-breast-cancer/

  ER and PR Testing assists in determining both types of treatment and the probability of reoccurrence. The type of treatment determined would be the one that minimizes the risk of reoccurrence. IBC is usually ER/PR negative. On the other hand, other inflammatory breast cancers are ER/PR positive. […] HER2. The status assists in determining whether drugs targeting the HER2 receptor play a role in treating cancer. IBC is often HER2 negative; however, it can have these receptors sometimes. […] After looking at the methods of IBC diagnosis, it can be established that it is not easy to diagnose it. After the tests are completed, the doctor reviews the results with the patient. The results are helpful in determining the spread of cancer in the body. It is called staging.

• #41 Defining and Demystifying Inflammatory Breast Cancer | Blog | AACR

  https://www.aacr.org/blog/2023/12/15/sabcs-2023-defining-and-demystifying-inflammatory-breast-cancer/

  A research group at Dana-Farber Cancer Institute aims to explore the risks and benefits of locoregional therapy through a prospective registry. […] Some researchers are working to identify IBC-specific drug targets to offer systemic therapy to more patients, but they have faced difficulties, explained Frederick Howard, MD, an instructor of medicine at the UChicago Medicine Comprehensive Cancer Center. […] While several groups have tried to identify a genomic signature characteristic of IBC, theyve found that IBC cases tend to be more genomically similar to non-IBC cases of the same molecular subtype, defined by hormone receptor and HER2 expression; no set of genomic factors could accurately differentiate IBC from non-IBC cases. […] Nevertheless, Howard identified a few molecular pathways that warrant further investigation.

• #42 South Texas Oncology and Hematology

  https://thestartcenter.com/inflammatory-breast-cancer.html

  Hormone-blockers, also known as endocrine therapy, is prescribed for hormone receptor positive tumors and is a type of systemic treatment, meaning it affects the entire body, not just the breast. […] If the cancer improves with chemotherapy, surgery is the next step. […] Radiation after mastectomy for IBC helps lower the risk of the cancer coming back in the treated breast or in nearby lymph nodes. […] Many patients with metastatic breast cancer gain great benefit from participating in a clinical trial study. […] If an inherited gene is found, treatment options can become more complex and the patient should consult with their healthcare team about the current guidelines of care.

• #43 Inflammatory Breast Cancer Program | Dana-Farber Cancer Institute

  https://www.dana-farber.org/cancer-care/treatment/breast-oncology/programs/inflammatory-breast-cancer

  Once a diagnosis of IBC is confirmed, we will schedule your appointment with a dedicated team, which can include medical, surgical, and radiation oncologists, as soon as possible. Our multidisciplinary team reviews all diagnostic imaging and coordinates further imaging or biopsies as needed, to ensure that the best information is available for treatment planning. […] IBC shares some outward similarities to mastitis and can be misdiagnosed at first. Mastitis sometimes involves a bacterial infection that is treated with antibiotics. IBC is not an infection and does not respond to antibiotics. If you are diagnosed with mastitis but don’t respond to antibiotic treatment within a week, you should ask your doctor about testing for inflammatory breast cancer.

• #44 Inflammatory Breast Cancer | Duke Health

  https://www.dukehealth.org/treatments/breast-cancer/inflammatory-breast-cancer

  Mammography, ultrasound, and/or MRI may be used to determine if the cancer is in the lymph nodes. […] Duke is one of the few places in the region to use a new imaging agent for PET scans to detect estrogen receptor-positive (ER+) breast cancer. […] Inflammatory breast cancer benefits from many types of treatment performed either alone or in combination. […] Its important to seek care from a major medical center like Duke, where a team of medical, surgical, and radiation oncologists combines their expertise to create a personalized treatment approach for your cancer. […] Your doctor will let you know if you are eligible to participate in clinical trials testing new types of targeted therapies. […] Your medical team is actively involved in inflammatory breast cancer research.

• #45 Inflammatory Breast Cancer Is Often Missed, But May Now Be Easier To Diagnose

  https://www.oncnursingnews.com/view/inflammatory-breast-cancer-is-often-missed-but-may-now-be-easier-to-diagnose

  The classic Hallmark with IBC patients is that some of these symptoms are [developing] in under 6 months. It is very quick. […] Tamargo agreed that raising awareness at the primary care provider level is a key point in improving time to treatment for these patients. […] Although she made it clear that this new tool will not be the only thing used to diagnosis someone, she is optimistic that it will help raise awareness and make diagnoses easier for clinicians. […] This tool will help prevent delays in getting patients treated, because the best thing for them to prevent becoming metastatic is getting treatment with chemotherapy as soon as possible.

• #46 Inflammatory Breast Cancer: Symptoms, When They Appear, and Diagnosis

  https://www.healthline.com/health/breast-cancer/inflammatory-breast-cancer-symptoms-come-and-go

  Symptoms of inflammatory breast cancer may fluctuate over time or become more intense, depending on this fast-growing cancers growth. […] In some cases, these symptoms can come and go and vary in severity or intensity, depending on how quickly the cancer is growing. […] IBC symptoms will not resolve on their own without treatment or intervention, so its important to talk with a doctor immediately if you have any of the symptoms mentioned above. […] If your doctor diagnoses IBC, treatment will begin right away. Treatment usually includes chemotherapy to reduce the size of the tumor(s), followed by surgery and radiation therapy. […] If youve noticed sudden changes to your breasts and are concerned it may be IBC, schedule an appointment with a doctor as soon as possible. […] The first symptoms may include breast discoloration (similar to a bruise), breast tenderness and pain, skin dimpling, and a change in the shape of your nipple (it may become flat or retract inside your breast).

Zobacz więcej